Epazz Blockchain Technology Providers Set to Launch Greenheart DeFi Mobile App
Chicago, Illinois–(Newsfile Corp. – February 4, 2021) – Epazz, Inc. (OTC Pink: EPAZ), a provider of blockchain technology, cryptocurrency mobile apps, smart contracts, and cloud-based business software solutions, announced today that the company is developing the Greenheart DeFi mobile application to trade Greenheart Punt tokens as the first distributed application (dApp) marketplace for Cannabidiol (CBD) oils products.
Greenheart CBD is an Irish owned company with a vision to bring the finest Irish made Cannabidiol (CBD) oils products from seed to shelf in Ireland. The company helps farmers to produce the best organic hemp crops and process them through cold press extraction machinery in the most natural way possible. The company has spent years researching extraction methods with full traceability from seed to shelf. It aims to create standardized cold-press extraction procedures and create the most effective CBD products for the end consumer.
Shaun Passley, Ph.D., CEO, and Chairman of Epazz, Inc., said in a comment: “What differentiates Greenheart Punt tokens from other tokens and cryptocurrencies is its sustainability. Greenheart CBD hemp company is profitable and revenue-producing. Global expansion through its DeFi platform is the next step in global expansion.”
Through collaboration with Epazz blockchain technology provider, Greenheart built the first distributed application (dApp) marketplace for CBD products. The company uses the industry-leading decentralized platform “Origin.” It enables token investors to use the platform to purchase Greenheart CBD products using Ethereum or the Greenheart Punt tokens. The dApp marketplace is now live and the company has issued the Greenheart Punt token to expand its scope to the CBD community, by offering its token holders a cost-effective and operationally efficient way to access the growing range of Greenheart CBD products.
The Greenheart mobile app will allow token holders to use their tokens to purchase current and future CBD products. Additionally, more Greenheart CBD Punt token holders mean rapid growth of the token community, allowing for developing advanced technology across its production process including AI, drone technology, and Big Data capabilities and analytics. It also enables easy payment processing using secure blockchain technology.
Epazz Inc. (www.epazz.com)
Epazz Inc. is a provider of blockchain apps and a cloud-based software company specializing in providing customized cloud applications to the corporate world, higher-education institutions, and the public sector. Epazz BoxesOS™ v3.0 is a complete web-based software package for small- to mid-size businesses, Fortune 500 enterprises, government agencies and higher education institutions. BoxesOS provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz’s other products include K9Sky.com kennel software and the Provitrac applicant tracking system.
Greenheart CBD (www.greenheartcbd.ie)
Greenheart CBD is an Irish owned company with a vision using advanced systems tracking plant health to bring the finest Irish grown and manufactured CBD products to the market. During CBD production data gathered from AI drone are used to provide meaningful insights and data tracing for farmers and producers. The company’s “Homogenized Cold Press” technology uses no chemicals, is low on energy consumption, and enables a zero-waste operation – producing the highest quality, organic verification, and end-to-end product traceability. The company launched its own product token – the Greenheart Punt – allowing its token holders to access its CBD products at the greatest possible discount. The Greenheart Punt token is backed by a real commodity – 1,000 liters of Greenheart’s CBD oil in year 1 (with a retail value of $4 million US dollars) – allowing token holders to redeem their tokens directly on the dApps marketplace for Greenheart CBD oil at a significant discount to the retail market price.
This is the “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by the use of forward-looking words such as “may,” “expect,” “intend,” “estimate,” “anticipate,” “believe” and “continue” (or the negation thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results or those implied by such forward-looking statements. Investors are cautioned that no forward-looking statement is a guarantee of future performance and that actual results may differ materially from those contemplated by such forward-looking statements. Epazz Inc. assumes no obligation and has no intention of updating these forward-looking statements. It has no obligation to update or correct information prepared by third parties that are not paid for by Epazz Inc. Investors are encouraged to review Epazz Inc.’s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC market filings, which contain general business information about the company’s operations, results of operations and risks associated with the company and its operations.
CONTACT: For more information, please contact:
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73589